1. Home
  2. XXII

as of 12-12-2025 4:00pm EST

$1.05
$0.09
-7.89%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Chart Type:
Time Range:
Founded: 1998 Country:
United States
United States
Employees: N/A City: WILLIAMSVILLE
Market Cap: 7.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 191.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.58 EPS Growth: N/A
52 Week Low/High: $0.78 - $287.27 Next Earning Date: 11-04-2025
Revenue: $20,346,000 Revenue Growth: 16.98%
Revenue Growth (this year): -24.28% Revenue Growth (next year): 136.46%

AI-Powered XXII Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 80.95%
80.95%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest 22nd Century Group Inc. News

XXII Breaking Stock News: Dive into XXII Ticker-Specific Updates for Smart Investing

All XXII News

Share on Social Networks: